ATC Group: C09BX01 Perindopril, amlodipine and indapamide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C09BX01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C09 Agents acting on the renin-angiotensin system
3 C09B ACE inhibitors, combinations
4 C09BX ACE inhibitors, other combinations
5 C09BX01

Active ingredients in C09BX01

Active Ingredient Description
Perindopril, Amlodipine and Indapamide

Combination of three antihypertensive components with complementary mechanisms to control blood pressure in patient with hypertension. Perindopril is an angiotensin converting enzyme inhibitor, indapamide, a chlorosulphamoyl diuretic and amlodipine, a calcium ion flux inhibitor of the dihydropyridine group.

Related product monographs

Title Information Source Document Type  
TRIPLIXAM Film-coated tablet Health Sciences Authority (SG) MPI, EU: SmPC

Medicines in this ATC group

Brazil (BR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Italy (IT)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.